BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26051021)

  • 1. Long-Term Worries after Colposcopy: Which Women Are at Increased Risk?
    Sharp L; Cotton SC; Cruickshank ME; Gray NM; Neal K; Rothnie K; Thornton AJ; Walker LG; Little J;
    Womens Health Issues; 2015; 25(5):517-27. PubMed ID: 26051021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA).
    Sharp L; Cotton S; Carsin AE; Gray N; Thornton A; Cruickshank M; Little J;
    Psychooncology; 2013 Feb; 22(2):368-80. PubMed ID: 22162138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12-month longitudinal study.
    O'Connor M; O'Leary E; Waller J; Gallagher P; D'arcy T; Flannelly G; Martin CM; McRae J; Prendiville W; Ruttle C; White C; Pilkington L; O'Leary JJ; Sharp L;
    Psychooncology; 2016 May; 25(5):597-604. PubMed ID: 26392040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial.
    Sharp L; Cotton S; Cruickshank M; Gray N; Smart L; Whynes D; Little J;
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):43-51. PubMed ID: 26376822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A normal colposcopy examination fails to provide psychological reassurance for women who have had low-grade abnormal cervical cytology.
    Cotton SC; Sharp L; Little J; Gray NM; Walker LG; Whynes DK; Cruickshank ME;
    Cytopathology; 2015 Jun; 26(3):178-87. PubMed ID: 25099940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Women's Differing Experiences of Distress after Colposcopy: A Qualitative Interview Study.
    O'Connor M; Waller J; Gallagher P; Martin CM; O'Leary JJ; D'Arcy T; Prendiville W; Flannelly G; Sharp L;
    Womens Health Issues; 2015; 25(5):528-34. PubMed ID: 26189936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
    Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
    BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.
    Fielding S; Rothnie K; Gray NM; Little J; Cruickshank ME; Neal K; Walker LG; Whynes D; Cotton SC; Sharp L;
    Psychooncology; 2017 Apr; 26(4):476-483. PubMed ID: 27297097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse psychological outcomes following colposcopy and related procedures: a systematic review.
    O'Connor M; Gallagher P; Waller J; Martin CM; O'Leary JJ; Sharp L;
    BJOG; 2016 Jan; 123(1):24-38. PubMed ID: 26099164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of psychological distress immediately following colposcopy.
    Kola-Palmer S; Walsh JC
    Psychooncology; 2015 Jul; 24(7):819-24. PubMed ID: 25581290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial.
    Sharp L; Cotton S; Little J; Gray NM; Cruickshank M; Smart L; Thornton A; Waugh N; Walker L;
    PLoS One; 2013; 8(12):e80092. PubMed ID: 24386076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of alternative management policies on health-related quality of life in women with low-grade abnormal cervical cytology referred for colposcopy.
    Whynes DK; Sharp L; Cotton SC; Cruickshank M; Gray NM; Little J; Waugh N
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):88-92. PubMed ID: 23481576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis.
    Bouchard-Fortier G; Paszat L; Murphy KJ
    J Obstet Gynaecol Can; 2013 Feb; 35(2):149-55. PubMed ID: 23470065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.